宏基因组学结合合成生物学法挖掘新型生物催化剂的研究进展

生物催化剂是具有催化活性的细胞和酶的统称,因其高效和环境友好的特性被广泛应用于工业、农业、医药和能源等领域。传统的生物催化剂挖掘技术依赖于生物分离及体外培养,在一定程度上阻碍了生物催化剂的发展。宏基因组学挖掘新型生物催化剂通过直接从环境样品中提取全部微生物的DNA,构建宏基因组文库,再基于功能活性和序列分析筛选新型生物催化剂,避免了微生物的分离培养。合成生物学是利用工程学原理,通过元件的设计,组合和系统的构建对生物途径、有机体或生物系统进行重新设计。综述了宏基因组学方法挖掘新型生物催化剂的最新研究进展,并对利用合成生物学方法改进宏基因组筛选新型生物催化剂的效率进行了讨论。     

宏基因组学结合合成生物学法挖掘新型生物催化剂的研究进展

生物催化剂是具有催化活性的细胞和酶的统称,因其高效和环境友好的特性被广泛应用于工业、农业、医药和能源等领域。传统的生物催化剂挖掘技术依赖于生物分离及体外培养,在一定程度上阻碍了生物催化剂的发展。宏基因组学挖掘新型生物催化剂通过直接从环境样品中提取全部微生物的DNA,构建宏基因组文库,再基于功能活性和序列分析筛选新型生物催化剂,避免了微生物的分离培养。合成生物学是利用工程学原理,通过元件的设计,组合和系统的构建对生物途径、有机体或生物系统进行重新设计。综述了宏基因组学方法挖掘新型生物催化剂的最新研究进展,并对利用合成生物学方法改进宏基因组筛选新型生物催化剂的效率进行了讨论,以期提高挖掘新型生物催化剂的效率。     

宏基因组学挖掘新型生物催化剂的研究进展

微生物蕴藏着大量具有工业应用潜力的生物催化剂。然而,传统培养方法只能从环境中获得不到1%的微生物。宏基因组学是通过提取某一特定环境中的所有微生物基因组DNA、构建基因组文库并对文库进行筛选,寻找和发现新的功能基因的一种方法。它绕过了微生物分离培养过程,成为研究环境样品中不可培养微生物的有力手段。因此,从宏基因组中挖掘新型生物催化剂一直倍受生物学家的关注。以下主要对宏基因组文库的样品来源、DNA提取方法、文库的构建和筛选策略的选择这4个方面的研究状况进行了综述,列举了近年来利用宏基因组技术所获得的新型生物催化剂,并对其今后的研究方向提出了展望。     

宏基因组学在纤维素酶研究中的应用进展

纤维素酶能降解纤维素,被广泛应用于生物修复、食品加工、化工合成等领域,开发高活力、广底物、耐高温高碱等极端条件的新型纤维素酶具有重要意义。宏基因组学以特定环境样品中微生物的基因组总和为研究对象,避开传统的微生物分离培养过程,为基因资源的开发、利用提供了新技术。文中结合本课题组的研究工作,综述了利用宏基因组学获取纤维素酶的策略,同时着重介绍利用宏基因组学从动物胃肠道、土壤等环境中获取纤维素酶的研究。     

海洋宏基因组学研究进展

宏基因组学作为研究微生物种群生态分布、群体遗传特征和基因相互作用的新兴学科,在未培养微生物资源的开发利用上取得了突破性进展,已成为海洋等极端环境中分离与鉴定新型工业酶制剂的有效工具。综述海洋宏基因组学研究进展,以及宏基因组学领域中如新一代测序技术等,以期为从海洋环境中开发具有工业潜力和应用价值的新型生物催化剂提供参考。     

宏基因组学:基本策略及在医学研究领域中的可能应用

宏基因组学（metagenomics）的提出是分子生物学领域的一个重要进展。在自然生境中有大量不可培养微生物的存在,无法通过培养法进行研究,而宏基因组学的策略则突破了这一束缚。宏基因组学是从生境中取得全部微生物的基因组,并进行系统研究的方法。该文介绍宏基因组学的基本情况,并着重探讨其在医学研究领域中的可能应用。     

宏基因组样本数据的分析比较与分类

宏基因组学研究试图通过测序并分析微生物群落的DNA序列,以理解环境微生物的组成及其与环境的交互作用。宏基因组学革命性地改变了微生物学,使得以免培养的方式研究复杂生物系统中的微生物群落成为可能。第二代测序技术的不断进步和生物信息学的高速发展促进了高通量宏基因组研究的发展,大批高质量的宏基因组数据不断产生并对科学界开放,宏基因组学的重要作用被科学界广泛认可。与此同时,对应个体不同健康状态和人体不同部位的大量宏基因组样本数据不断产生,使得比较和分类宏基因组样本在微生物学研究上变得更加重要,比较宏基因组学成为宏基因组学的重要分支。主要介绍了宏基因组数据的分析比较,以及样本分类的相关研究和算法。     

宏基因组学研究进展

不可培养微生物占据微生物总数的99%以上, 这己成为微生物资源开发利用的一个限制性因素。宏基因组学是通过提取某一环境中的所有微生物基因组DNA、构建基因组文库及对文库进行筛选寻找和发现新的功能基因及活性代谢产物的一种方法。它避开了微生物分离培养的过程, 极大地扩展了微生物资源的利用空间, 是现代基因工程一个新的发展方向和研究热点。本文主要对宏基因组的DNA提取方法、文库的构建、筛选策略的选择及近年来宏基因组学在各领域中的应用研究现状进行了综述。     

宏基因组学应用于耐盐酶类及耐盐基因研究的进展

耐盐酶在高盐浓度下仍具备催化活性和稳定性,在高盐食品和海产品加工、洗涤及其它高盐环境生物技术领域被广泛应用;耐盐基因在高盐条件下可以使微生物维持正常功能,获取并研究不同环境中的耐盐基因对揭示微生物的耐盐机制,以及实现其在高盐环境中的定向应用具有的重要意义。宏基因组学避开纯培养技术探知微生物的多样性及其功能,为我们提供了一种发现新基因、开发新的微生物活性物质和研究微生物群落结构及其功能的新技术。文中结合本课题组的研究工作,综述了利用宏基因组学获取耐盐酶类及耐盐基因的策略,同时着重介绍利用宏基因组学从海洋、土壤、胃肠道等环境中获取耐盐酶类及耐盐基因的研究。     

环境微生物宏基因组学研究中的生物信息学方法

高通量测序技术的发展促进了组学技术在环境微生物研究中的广泛应用,而宏基因组学是目前最为关键和成熟的组学方法。生物信息学在微生物宏基因组学研究中具有至关重要的作用。它贯穿于宏基因组学的数据收集和存储、数据处理和分析等各个阶段,既是宏基因组学推广的最大瓶颈,也是目前宏基因组学研究发展的关键所在。本文主要介绍和归纳了目前在高通量宏基因组测序中常用的生物信息学分析平台及其重要的信息分析工具。未来几年之内,测序成本的下降和测序深度的增加将进一步增大宏基因组学研究在数据存储、数据处理和数据挖掘层面的难度,因此相应生物信息学技术与方法的研究和发展也势在必行。近期内我们应该首先加强基础性分析和存储平台的建设以方便普通环境微生物研究者使用,同时针对目前生物信息分析的瓶颈步骤和关键任务重点突破,逐步发展。     

New applications of biocatalysts.

The development of new biocatalytic applications continues to advance in several directions. Over the past year, new enzymes have been discovered and their potential in biocatalyst applications has been researched. In addition, new chemical and genetic modifications have been made in the development of novel fermentation processes.     

Efficient biocatalyst for large-scale synthesis of cephalosporins, obtained by combining immobilization and site-directed mutagenesis of penicillin acylase

We describe the rational design of a new efficient biocatalyst and the development of a sustainable green process for the synthesis of cephalosporins bearing a NH? group on the acyl side chain. The new biocatalyst was developed starting from the WT penicillin acylase (PA) from Escherichia coli by combining enzyme mutagenesis, in position α146 and β24 (βF24A/αF146Y), and immobilization on an appropriate modified industrial support, glyoxyl Eupergit C250L. The obtained derivative was used in the kinetically controlled synthesis of cephalexin, cefprozil and cefaclor and compared to the WT-PA and an already described mutant, PA-βF24A, with improved properties. The new biocatalyst posses a very high ratio between the rates of the synthesis and two undesired hydrolyses (acylating ester and the amidic product). In particular, a very low amidase activity was observed with PA-βF24A/αF146Y and, consequently, the hydrolysis of the produced antibiotic was avoided during the process. Taking advantage of this property, higher conversions in the synthesis of cephalexin (99% versus 76%), cefaclor (99% versus 65%) and cefprozil (99% versus 60%) were obtained compared to the WT enzyme. Furthermore, the new mutant also show a higher synthetic activity compared to PA-βF24A immobilized on the same support, allowing the maximum yields to be achieved in very short reaction times. The production of cephalexin with the immobilized βF24A/αF146Y acylase has been developed on a pre-industrial scale (30 l). After 20 cycles, the average yield was 93%. The biocatalyst showed good stability properties and no significant decrease in performance.     

D-malate production by permeabilized Pseudomonas pseudoalcaligenes; optimization of conversion and biocatalyst productivity

For the development of a continuous process for the production of solid D-malate from a Ca-maleate suspension by permeabilized Pseudomonas pseudoalcaligenes, it is important to understand the effect of appropriate process parameters on the stability and activity of the biocatalyst. Previously, we quantified the effect of product (D-malate2 -) concentration on both the first-order biocatalyst inactivation rate and on the biocatalytic conversion rate. The effects of the remaining process parameters (ionic strength, and substrate and Ca2 + concentration) on biocatalyst activity are reported here. At (common) ionic strengths below 2 M, biocatalyst activity was unaffected. At high substrate concentrations, inhibition occurred. Ca2+ concentration did not affect biocatalyst activity. The kinetic parameters (both for conversion and inactivation) were determined as a function of temperature by fitting the complete kinetic model, featuring substrate inhibition, competitive product inhibition and first-order irreversible biocatalyst inactivation, at different temperatures simultaneously through three extended data sets of substrate concentration versus time. Temperature affected both the conversion and inactivation parameters. The final model was used to calculate the substrate and biocatalyst costs per mmol of product in a continuous system with biocatalyst replenishment and biocatalyst recycling. Despite the effect of temperature on each kinetic parameter separately, the overall effect of temperature on the costs was found to be negligible (between 293 and 308 K). Within pertinent ranges, the sum of the substrate and biocatalyst costs per mmol of product was calculated to decrease with the influent substrate concentration and the residence time. The sum of the costs showed a minimum as a function of the influent biocatalyst concentration.     

生物法生产D-塔格糖的研究进展

D-塔格糖具有多种独特的生理特性与功能,近年来已被发达国家开发作为具有高经济附加值的功能性甜味剂进行销售。D-塔格糖的商业化生产长期以来依赖化学催化法,随着20世纪90年代利用L-阿拉伯糖异构酶(简称L-AI酶)催化D-半乳糖制备D-塔格糖技术的兴起,生物法生产D-塔格糖成为了新的发展趋势。结合笔者所在课题组近年来的研究成果,就D-塔格糖生物法生产工艺的研究现状和前景进行综述与展望。     

Kinetics of enzymatic degradation of cyanide

CYANIDASE(@) is a new enzyme preparation capable of degrading cyanide in industrial wastewaters to ammonia and formate in an apparently one-step reaction, down to very low concentrations. This enzyme has both a high selectivity and affinity toward cyanide. A granular form of the biocatalyst was used in a recirculation fixed bed reactor in order to characterize the new biocatalyst with respect to pH, ionic strength, common ions normally present in wastewaters, mass transfer effects, and temperature. Long term stability was investigated. The kinetics of the enzymatic degradation of cyanide were studied in a batch reactor using the powdered immobilized enzyme preparation and modeled using a simple Michaelis-Menten equation.     

Maximizing the stability of metabolic engineering‐derived whole‐cell biocatalysts

A systematic and powerful knowledge‐based framework exists for improving the activity and stability of chemical catalysts and for empowering the commercialization of respective processes. In contrast, corresponding biotechnological processes are still scarce and characterized by case‐by‐case development strategies. A systematic understanding of parameters affecting biocatalyst efficiency, that is, biocatalyst activity and stability, is essential for a rational generation of improved biocatalysts. Today, systematic approaches only exist for increasing the activity of whole‐cell biocatalysts. They are still largely missing for whole‐cell biocatalyst stability. In this review, we structure factors affecting biocatalyst stability and summarize existing, yet not completely exploited strategies to overcome respective limitations. The factors and mechanisms related to biocatalyst destabilization are discussed and demonstrated inter alia based on two case studies. The factors are similar for processes with different objectives regarding target molecule or metabolic pathway complexity and process scale, but are in turn highly interdependent. This review provides a systematic for the stabilization of whole‐cell biocatalysts. In combination with our knowledge on strategies to improve biocatalyst activity, this paves the way for the rational design of superior recombinant whole‐cell biocatalysts, which can then be employed in economically and ecologically competitive and sustainable bioprocesses.     

Countercurrent multistage fluidized bed reactor for immobilized biocatalysts: I. Modeling and simulation

For the application of immobilized enzymes, fixed bed reactors are used almost exclusively. Fixed bed reactors have specific disadvantages, especially for processes with a deactivating catalyst. Therefore, we have studied a novel reactor type with continuous transport of the immobilized biocatalyst. Flow of biocatalyst is countercurrent to the substrate solution. Because of a stagewise reactor design, back-mixing of biocatalyst is very limited and transport is nearly plug flow. The reactor operates at a constant flow rate and conversion, due to constant holdup of catalytic activity. The reactor performance is compared with a configuration of fixed bed reactors. For reactions in the first-order regime, enzyme requirements in this new reactor are slightly less than for fixed bed processes. The multistage fluidized bed appears to be an attractive reactor design to use biocatalyst to a low residual activity. However, nonuniformity of the particles might affect plug flow transport of the biocatalyst. A laboratory scale reactor and experiments are described in Part II(1) of this series. Hydrodynamic design aspects of a multistage fluidized bed are discussed in more detail in Part III.(2).     

Stability of biocatalysts on the basis of carrageenan-immobilized Escherichia coli during continuous synthesis of L-malic acid

Continuous enzymatic synthesis of L-malic acid from potassium fumarate in packed-bed flow reactors was investigated. Carrageenan-immobilized Escherichia coli cells were used as a biocatalyst. The operational stability of the biocatalyst fumarase activity was studied, and conditions for preserving high activity of the biocatalyst were determined.     

Immobilization of lipase B from Candida antarctica on porous styrene-divinylbenzene beads improves butyl acetate synthesis

A new biocatalyst of lipase B from Candida antarctica (MCI-CALB) immobilized on styrene-divinylbenzene beads (MCI GEL CHP20P) was compared with the commercial Novozym 435 (immobilized lipase) in terms of their performances as biocatalysts for the esterification of acetic acid and n-butanol. The effects of experimental conditions on reaction rates differed for each biocatalyst, showing different optimal values for water content, temperature, and substrate molar ratio. MCI-CALB could be used at higher acid concentrations, up to 0.5 M, while Novozym 435 became inactivated at these acid concentrations. Although Novozym 435 exhibited 30% higher initial activity than MCI-CALB for the butyl acetate synthesis, the reaction course was much more linear using the new preparation, meaning that the MCI-CALB allows for higher productivities per cycle. Both preparations produced around 90% of yield conversions after only 2 h of reaction, using 10% (mass fraction) of enzyme. However, the main advantage of the new biocatalyst was the superior performance during reuse. While Novozym 435 was fully inactivated after only two batches, MCI-CALB could be reused for six consecutive cycles without any washings and keeping around 70% of its initial activity. It is proposed that this effect is due to the higher hydrophobicity of the new support, which does not retain water or acid in the enzyme environment. MCI-CALB has shown to be a very promising biocatalyst for the esterification of small-molecule acids and alcohols.     

Accelerated biocatalyst stability testing for process optimization

The deactivation of protein biocatalysts even at relatively low temperatures is one of the principal drawbacks to their use. To aid in the development of novel biocatalysts, we have derived an equation for both time- and temperature-dependent activity of the biocatalyst based on known concepts such as transition state theory and the Lumry-Eyring model. We then derived an analytical solution for the total turnover number (ttn), under isothermal operation, as a function of the catalytic constant kcat, the unfolding equilibrium constant K, and the intrinsic first-order deactivation rate constant(s) k(d,i). Employing an immobilized glucose isomerase biocatalyst in a CSTR and utilizing a linear temperature ramp beyond the Tm of the enzyme, we demonstrate an accelerated method for extracting the thermodynamic and kinetic constants describing the biocatalyst system. In addition, we demonstrate that the predicted biocatalyst behavior at different temperatures and reaction times is consistent with the experimental observations.